Cutaneous T cell lymphomas (CTCL) comprise most cases, with neoplastic cells commonly exhibiting a CD4+CD8- immunophenotype. This evidence concerns the gene CD4 and primary cutaneous T-cell non-Hodgkin lymphoma.